Basis: (FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-10-06T16:36:52.932Z.
Calculation as of: 2026-10-06T16:36:52.932Z.
Quote observation: 2026-10-06T16:35:11.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 5811ce025d9976e80ea69b9f8bae613fc78d61205a97c72640e2bc4d521a59ba
PEG RATIO
N/A
Eloxx Pharmaceuticals, Inc.
Market Cap
$51.72M
PEG Ratio
N/A
| NAME | MARKET CAP | PEG RATIO |
|---|---|---|
| Eloxx Pharmaceuticals, Inc. (ELOX) | $51.72M | N/A |
| NOMAD Power Solutions, Inc. (NMAD)vs › | $52.28M | N/A |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $52.46M | N/A |
| biote Corp. (BTMD)vs › | $51.61M | N/A |
| eXoZymes, Inc. (EXOZ)vs › | $51.42M | N/A |
| Rani Therapeutics Holdings, Inc. (RANI)vs › | $51.20M | N/A |
| Clene Inc. (CLNN)vs › | $51.05M | N/A |
| Envoy Medical, Inc. (COCH)vs › | $51.72M | N/A |
| Spectral AI, Inc. (MDAI)vs › | $53.62M | N/A |
| INmune Bio, Inc. (INMB)vs › | $50.51M | N/A |
PEG Ratio
N/A
P/E Ratio
N/A
PEG Ratio = P/E Ratio / 5-Year Diluted EPS CAGR (%)
The PEG ratio divides the price-to-earnings ratio by the company's five-year compound annual growth rate of diluted EPS, expressed in percent. A P/E of 20 and a five-year diluted EPS CAGR of 10% give a PEG of 2.0. The growth is reported, historical earnings growth from annual statements, not an analyst forecast. A PEG near 1 is often read as fairly priced for its growth; lower can mean cheaper relative to growth. The ratio is N/A when the P/E is unavailable or not positive, or when the five-year diluted EPS CAGR is unavailable or not positive. Each day of the history uses the CAGR that was known on that day.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
